Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
SpaceX held firm through a choppy month, outperforming peers in the space stock group. The market’s rotation favored ...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Investors chasing income may be chasing sky-high yields that hide fragile payouts. Three BDCs illustrate growing payo...
Click n’ Close appoints Rachel Fatino to head its correspondent operations, aiming to expand partnerships and tighten...
When a blue-chip stock slips, it can be more noise than signal. This article dives into why shares walmart sinking to...
With the USMCA review approaching in 2026, two key signals will shape how investors position in Mexico and related ma...
The European Union and Mercosur clinched a landmark free-trade agreement after 25 years of negotiations, linking 700 ...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
A small-cap AI marketing platform is selling at $0.91 per share in a Reg A+ offering, aiming to replicate early tech ...
A multi-decade rally faces a valuation crossroads as the CAPE gauge sits near historic highs. Here’s how years market...
A retiree with a large 401(k) balance faces steep taxation on Social Security under a rule unchanged since 1984. The ...